Patents Assigned to GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD.
  • Patent number: 11464794
    Abstract: The present invention relates to an alginic oligosaccharic diacid composition comprising a mannuronic diacid of Formula (IV) or a pharmaceutically acceptable salt thereof, wherein n is an integer selected from 1 to 9, m is selected from 0, 1 or 2, m? is selected from 0 or 1, and wherein the total weight of alginic oligosaccharic diacid wherein n=1-5 accounts for more than 60% of the total weight of the composition; the total weight of guluronic acids accounts for less than 50% of the total weight of the composition.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: October 11, 2022
    Assignees: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD., SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Meiyu Geng, Zhenqing Zhang, Yingshen Jin, Zhongping Xiao, Jian Ding
  • Patent number: 11406659
    Abstract: The present invention relates to the use of mannuronic diacid oligosaccharide composition in the treatment of inflammation.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: August 9, 2022
    Assignees: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD., SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Meiyu Geng, Xianliang Xin, Zhenqing Zhang, Jian Ding
  • Patent number: 11406654
    Abstract: The present invention relates to the use of mannuronic diacid oligosaccharide composition in the treatment of Parkinson's disease.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: August 9, 2022
    Assignees: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD., SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Meiyu Geng, Xianliang Xin, Xiaoguang Du, Zhenqing Zhang, Jian Ding
  • Patent number: 11406653
    Abstract: The present invention relates to the use of mannuronic diacid oligosaccharide composition in the treatment of pain.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: August 9, 2022
    Assignees: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD., SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Meiyu Geng, Xianliang Xin, Zhenqing Zhang, Jian Ding
  • Patent number: 11406651
    Abstract: The present invention relates to the application of mannuronic diacid oligosaccharide composition in the treatment of vascular dementia.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: August 9, 2022
    Assignees: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD., SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Meiyu Geng, Xianliang Xin, Xiaoguang Du, Zhenqing Zhang, Jian Ding
  • Patent number: 11406652
    Abstract: The present invention relates to the use of mannuronic diacid oligosaccharide composition in the treatment of diabetes.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: August 9, 2022
    Assignees: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD., SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Meiyu Geng, Xianliang Xin, Zhenqing Zhang, Jian Ding
  • Patent number: 11384111
    Abstract: The present invention relates to a mannuronic diacid oligosaccharide composition, comprising a mannuronic diacid of Formula (III) or a pharmaceutically acceptable salt thereof, wherein n is an integer from 1 to 9, m is 0, 1 or 2, and m? is 0 or 1, and wherein the total weight of mannuronic diacids wherein n=1-5 is 80-95% of the total weight of the composition, and the ratio of the total weight of mannuronic diacids wherein n=1-3 to the total weight of mannuronic diacids wherein n=4-7 is between 1.0 and 3.5.
    Type: Grant
    Filed: December 27, 2017
    Date of Patent: July 12, 2022
    Assignee: GREEN VALLEY (SHANGHAI) PHARMACEUTICAL CO., LTD. SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES
    Inventors: Meiyu Geng, Jian Ding, Zhenqing Zhang, Zhongping Xiao, Xiaoguang Du, Xianliang Xin
  • Patent number: 11155569
    Abstract: The present invention relates to a method for degrading a polysaccharide in the field of food, medicine or chemical industry. In particular, a molecular chain of the polysaccharide is broken by ozone into polysaccharides with smaller molecular weights, oligoses and/or oligosaccharides. The polysaccharides include linear or branched glycans extracted from plants, traditional Chinese medicinal materials, animals, fungi, or microorganisms and sulfated polysaccharides or esterified polysaccharides formed by sulfation or esterification thereof. As an oxidizing agent in the reaction, the ozone can be used alone or can be used under the catalysis of a base, a metal ion, hydrogen peroxide, UV light, or activated carbon to accelerate the reaction.
    Type: Grant
    Filed: December 27, 2017
    Date of Patent: October 26, 2021
    Assignee: GREEN VALLEY (SHANGHAI) PHARMACEUTICALS CO., LTD.
    Inventors: Zhongping Xiao, Zhenqing Zhang, Meiyu Geng, Jian Ding